NPI registry status
Active
2026 NPPES data Specialist NPI 1396801759 MD
Verify on CMS → Gerard Vitale, MD
Specialist in Glen Cove, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,567 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
244
Medicare Part D claims · 69 beneficiaries · Specialist avg: 2K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
67.3/100
▼ 16 pts below national avg 83.5 · Mid-tier
Industry payments
$455.71
9 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Gerard Vitale, MD reported a CMS MIPS final score of 67.3/100 - below the 83.5 national average - and filed 244 Medicare Part D claims in 2024.
- 67.3/100
- MIPS score · -16 vs avg
- 244
- Part D claims, 2024
- 67%
- generic prescribing
- $455.71
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Gerard Vitale, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1396801759), first enumerated 12/29/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 244 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 67.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Industry payment transparency
$455.71 in reported industry payments (9 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Gerard Vitale, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1396801759 · Specialist
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-LOW · RX-LIGHT · BOOK-MID · PHOTO-FINISH
- NPI-10 1396801759
- ENUM-LEGACY 2006
- TAX-MEGA 70K Specialist
- MIPS-LOW 67.3/100
- RX-LIGHT 244
- BOOK-MID 23,149 in New York
- PHOTO-FINISH Jon Nichols · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Arup Maitra · lo…
Arup Maitra
67.2 MIPS pts
- Jordan Youngerma…
Jordan Youngerman
67.2 MIPS pts
- Vitale · this pr…
Vitale · this provider
67.3 MIPS pts
- Jon Nichols · near
Jon Nichols
67.3 MIPS pts
- Anmar Alrabadi ·…
Anmar Alrabadi
67.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Gerard Vitale, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
67 ≥ 8th percentile 8% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Gerard Vitale, MD sits
This provider among specialist peers
Across the 4,261 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Gerard Vitale, MD writes more Part D claims than 26% of them and scores higher on MIPS quality than 20% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one specialist peer from a representative sample of 60; the gold marker is Gerard Vitale, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Gerard Vitale, MD?
Below national averagePrimary specialty
Specialist
Medicare Part D claims
244 84% vs specialty avg
MIPS final score
67.3/100 16.2 pts vs avg
Specialty distribution in New York
How Specialist compares to other specialties among New York providers
Medicare quality performance, MIPS
Gerard Vitale, MD's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 67.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1396801759 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 12/29/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
67.2957
Final Score
Measured-score avg: 83.5
34.5913
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Gerard Vitale, MD. Source: openpaymentsdata.cms.gov.
Total received
$456
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Gerard Vitale, MD. To verify Gerard Vitale, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Gerard Vitale, MD - brand share 33.0%
Specialist average
33% brand-name claims vs 67% generic, on 244 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
244
Total Claims
$85K
Total Drug Cost
69
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 417
- Total Day Supply
- 11,668
- Brand vs Generic
- 33% brand / 67% generic
- Brand Drug Cost
- $83K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 78.1 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 59% female / 41% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Gerard Vitale, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Cilostazol
Cilostazol
50 claims
- Eliquis
Eliquis
45 claims
- Clopidogrel
Clopidogrel
34 claims
- Xarelto
Xarelto
33 claims
- Diazepam
Diazepam
28 claims
- Pentoxifylline 15
Pentoxifylline
15 claims
- Gabapentin 12
Gabapentin
12 claims
| Drug | Claims |
|---|---|
| Cilostazol | 50 |
| Eliquis Apixaban | 45 |
| Clopidogrel Clopidogrel Bisulfate | 34 |
| Xarelto Rivaroxaban | 33 |
| Diazepam | 28 |
| Pentoxifylline | 15 |
| Gabapentin | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Gerard Vitale, MD fits within the Specialist landscape nationally.
69,567
Specialist Providers in US
55
States with Specialist
1,524
Avg Claims per Provider
Gerard Vitale, MD's 244 claims are below the specialty average of 1,524.
Nationwide Specialist peers with similar MIPS or enrollment year
Two federal-record peer sets for Vitale, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (67.3 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Specialist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Vitale.
One of 23,149 Specialist providers enrolled in New York, 5 are shown here.
Caroline A Borum
Oswego, NY
Kerry Aaron
Fairport, NY
Bracha Aaronson
SPECIAL EDUCATOR
Brooklyn, NY
Gayle Aaronson
SPECIALIST
New York, NY
Kerly Abad Avila
New York, NY
Compare Specialist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Gerard Vitale, MD's specialty? ▼
Gerard Vitale, MD specializes in Specialist and practices in Glen Cove, New York. Credentials: MD.
How much does Gerard Vitale, MD prescribe under Medicare Part D? ▼
In 2024, Gerard Vitale, MD wrote 244 Medicare Part D claims totaling $85K in drug costs for 69 beneficiaries.
What is Gerard Vitale, MD's Medicare quality score? ▼
Gerard Vitale, MD has a CMS MIPS Final Score of 67.3/100 (Quality: 34.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Gerard Vitale, MD located? ▼
Gerard Vitale, MD is located at 1 SCHOOL STREET, Glen Cove, NY, 11542. Phone: (516) 759-5559.
What is Gerard Vitale, MD's NPI number? ▼
Gerard Vitale, MD's National Provider Identifier (NPI) is 1396801759, issued on 12/29/2006.
Does Gerard Vitale, MD prescribe more brand-name or generic drugs? ▼
Gerard Vitale, MD's prescribing is 33% brand-name and 67% generic drugs by claim count, with $83K in brand drug costs.
How many Specialist providers are there in the US? ▼
There are 69,567 Specialist providers across 55 states in the US. The average Specialist provider writes 1,524 Medicare Part D claims per year.
What drugs does Gerard Vitale, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Gerard Vitale, MD's most frequently prescribed drugs include Cilostazol, Eliquis, Clopidogrel. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Gerard Vitale, MD accept Medicare? ▼
Gerard Vitale, MD appears in CMS Medicare data with 244 Part D claims and 69 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Gerard Vitale, MD's credentials? ▼
Gerard Vitale, MD's NPI is 1396801759 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.